The Rocky Road to Legacy: Lessons from the 2010 FIFA World Cup South Africa Stadium Program

This article describes how the management and organization of the South African 2010 FIFA World Cup stadium program shaped the current legacy of an oversupply of overdesigned and underutilized stadiums. The article identifies seven key factors that explain the differences between expected benefits and the actual legacy. Identification of these factors contributes to the increasing academic interest in explaining the poor legacy outcomes of mega‐events. In conclusion, we recommend that future host country governments defragment their stadium programs by establishing a World Cup Delivery Authority (WCDA), with responsibility for the leadership and coordination of the stadium program.     

Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants

Objective: To assess long-term healthcare costs related to ischemic stroke and systemic embolism (stroke/SE) and major bleeding (MB) events in patients with non-valvular atrial fibrillation (NVAF) treated with non-vitamin K antagonist oral anticoagulants (NOACs).

Materials and methods: Optum’s Clinformatics Data Mart database from 1/2009–12/2016 was analyzed. Adult patients with ≥1 stroke/SE hospitalization (index date) were matched 1:1 to patients without stroke/SE (random index date), based on propensity scores. Patients with an MB event were matched to patients without MB. All patients had an NOAC dispensing overlapping index date, ≥12?months of eligibility pre-index date, and ≥1 NVAF diagnosis. The observation period spanned from the index date until the earliest date of death, switch to warfarin, end of insurance coverage, or end of data availability. Mean costs were evaluated: (1) per-patient-per-year (PPPY) and (2) at 1, 2, 3, and 4?years using Lin's method.

Results: The cost differences were, respectively, $48,807 and $28,298 PPPY for NOAC users with stroke/SE (n?=?1,340) and those with MB (n?=?3,774) events compared to controls. Cost differences of patients with vs without stroke/SE were $49,876, $51,627, $57,822, and $60,691 at 1, 2, 3, and 4?years post-index, respectively (p?p?Limitations: Limitations include unobserved confounders, coding and/or billing inaccuracies, limited sample sizes over longer follow-up, and the under-reporting of mortality for deaths occurring after 2011.

Conclusions: The incremental healthcare costs incurred by patients with vs without stroke/SE was nearly twice as high as those of patients with vs without MB. Moreover, each additional year up to 4?years after the first event was associated with an incremental cost for patients with a stroke/SE or MB event compared to those without an event.     

3S技术在国家重点建设工程项目中的应用——以京沪高铁项目(天津段)为例

3S技术是测量技术发展史的一次重大突破,给测量领域带来了新的生命力,并已推广应用在国家基础建设的各个方面。本文以京沪高铁天津段这样的国家重点建设工程项目为例,介绍了3S技术在该项目从土地规划到建设运营方面的应用。     

上海合作组织命运共同体:一项研究议题

构建上海合作组织命运共同体是中国政府提出的关于促进上海合作组织长远发展的重大倡议。由于上海合作组织命运共同体理念的提出时日尚短,学术界关于该理念的研究尚未全面启动。要使上海合作组织命运共同体理念成为一个有效的研究议题,不仅需要明晰上海合作组织命运共同体的具体内涵,而且需要将其纳入国际共同体、国际组织和大国外交等议题的研究,提炼出一些具有普遍性的理论命题。就攸关上海合作组织命运共同体构建的重大问题而言,至少需要回答上海合作组织命运共同体提出的理论与实践意义、上海合作组织命运共同体构建应遵循的基本路径、上海合作组织命运共同体构建的基础和条件、上海合作组织命运共同体构建面临的挑战与障碍、学术界能为上海合作组织命运共同体构建提供的对策建议等重大问题。在此过程中,学术界还需将其与周边命运共同体、人类命运共同体等家族相似性的概念纳入同一研究视域,以澄清上海合作组织命运共同体的内涵与外延,辨识上海合作组织命运共同体演变的动力与机制,并从理论层面提炼上海合作组织发展经验的特殊性与普遍性。     

The Three Faces of Labor: Sustainability and the Next Wave of Automation

This article develops a model of three faces of labor from Figart, Mutari, and Power’s three faces of wages. This is integrated with sustainability models to locate the process of human and social capital formation and explore issues arising from technological change. The latest wave of automation, involving robotics and artificial intelligence, is expected to be an even greater challenge for worker well-being than globalization and immigration. The model supports a new narrative around labor that incorporates the caring economy as well as a framework for thinking about labor issues and long-term well-being.     

高职营销专业实训教学模式探索与实践

为了弥补高职营销专业的学生在专业学习过程中社会实践的不足,教师可以通过科学实用的案例任务的设计和开放式的小组合作学习方式的有机组合,开展课程实训,培养提升学生综合职业能力,提高教学效果和效率。     

以马斯洛需求层次理论指导会计职业道德教育

本文提出基于马斯洛需求层次理论,以＂需求实现＂保障会计职业道德教育实效,结合学生的职业生涯发展,以＂需求愿景＂构建会计职业道德约束,并提出系统重构与实施会计专业人才培养方案,为会计职业道德教育提供了新的思路与实践方向。     

Major bleeding risk and healthcare economic outcomes of non-valvular atrial fibrillation patients newly-initiated with oral anticoagulant therapy in the real-world setting

Aims: This study compared the risk for major bleeding (MB) and healthcare economic outcomes of patients with non-valvular atrial fibrillation (NVAF) after initiating treatment with apixaban vs rivaroxaban, dabigatran, or warfarin.

Methods: NVAF patients who initiated apixaban, rivaroxaban, dabigatran, or warfarin were identified from the IMS Pharmetrics Plus database (January 1, 2013–September 30, 2015). Propensity score matching (PSM) was used to balance differences in patient characteristics between study cohorts: patients treated with apixaban vs rivaroxaban, apixaban vs dabigatran, and apixaban vs warfarin. Risk of hospitalization and healthcare costs (all-cause and MB-related) were compared between matched cohorts during the follow-up.

Results: During the follow-up, risks for all-cause (hazard ratio [HR]?=?1.44, 95% confidence interval [CI]?=?1.2–1.7) and MB-related (HR?=?1.57, 95% CI?=?1.0–2.4) hospitalizations were significantly greater for patients treated with rivaroxaban vs apixaban. Adjusted total all-cause healthcare costs were significantly lower for patients treated with apixaban vs rivaroxaban ($3,950 vs $4,333 per patient per month [PPPM], p?=?.002) and MB-related medical costs were not statistically significantly different ($100 vs $233 PPPM, p?=?.096). Risk for all-cause hospitalization (HR?=?1.98, 95% CI?=?1.6–2.4) was significantly greater for patients treated with dabigatran vs apixaban, although total all-cause healthcare costs were not statistically different. Risks for all-cause (HR?=?2.22, 95% CI?=?1.9–2.5) and MB-related (HR?=?2.05, 95% CI?=?1.4–3.0) hospitalizations were significantly greater for patients treated with warfarin vs apixaban. Total all-cause healthcare costs ($3,919 vs $4,177 PPPM, p?=?.025) and MB-related medical costs ($96 vs $212 PPPM, p?=?.026) were significantly lower for patients treated with apixaban vs warfarin.

Limitations: This retrospective database analysis does not establish causation.

Conclusions: In the real-world setting, compared with rivaroxaban and warfarin, apixaban is associated with reduced risk of hospitalization and lower healthcare costs. Compared with dabigatran, apixaban is associated with lower risk of hospitalizations.     

学生创新实践平台的构建与探索

近年来,高职学生的专业能力获得了很大的提高,但是高职学生的整体素质仍有不少弱点,集中表现在缺乏创新意识,以及缺乏主动学习的能力。本文构建了一个自动化专业学生创新实践平台,通过学生的培训、交流、参加技能竞赛、实验室设备维修等活动,实现学生创新能力的培养,取得了不错的成果。     

翻译专业本科阶段口译能力发展的现状及途径

本科阶段的口译翻译训练应有意识地培养学生进行双语转换思维的模式,高校应从课程设置、师资力量以及口译能力的课外练习三个方面加强翻译本科专业的口译能力培养。